Latest DEF 14A proxy statements

Citizens, Inc. has announced its 2026 Annual Meeting of Shareholders, set for June 16, 2026, to elect directors, ratify auditor appointment, approve executive compensation, and vote on an amended incentive plan.

Nocopi Technologies, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026, with key proposals including director election and auditor ratification.

Archer Aviation Inc. is holding its 2026 Annual Meeting of Stockholders on June 26, 2026, to vote on key proposals including the company's redomestication from Delaware to Texas.

AMC Global Media Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 16, 2026, to elect directors, ratify auditors, and vote on executive compensation and stock plans.

Esquire Financial Holdings, Inc. has issued its proxy statement for the Annual Meeting of Stockholders scheduled for May 28, 2026, detailing proposals for director elections, auditor ratification, and executive compensation.

Neonode Inc. announces its 2026 Annual Meeting of Stockholders to be held on June 17, 2026, with key proposals including director elections, auditor ratification, and executive compensation.

Acrivon Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 17, 2026, to elect directors and ratify auditor appointment.

Valion Bio, Inc. has issued its definitive proxy statement detailing proposals for its 2026 Annual Meeting of Stockholders, including director elections, equity plan amendments, and ratification of its accounting firm.

StandardAero, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 25, 2026, and outlined key proposals including director elections and auditor ratification.

SPAR Group, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 11, 2026, to elect directors, ratify auditor, and approve executive compensation and a new stock plan.

MeiraGTx Holdings plc announces its 2026 Annual General Meeting of Shareholders, scheduled for June 11, 2026, to elect directors and ratify auditor appointment.

Omeros Corporation announces its 2026 Annual Meeting of Shareholders, to be held virtually on June 18, 2026, with key proposals including director elections and executive compensation.

Virginia National Bankshares Corporation has announced its 2026 Annual Meeting of Shareholders, scheduled for June 25, 2026, to elect directors, vote on executive compensation, and ratify auditor appointments.

Innventure, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 17, 2026, to elect three Class II directors and ratify the appointment of its independent auditor.

QNB Corp. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, detailing proposals for director elections, an employee stock purchase plan, and auditor ratification.

Pyxis Oncology, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 15, 2026, to elect directors and ratify auditor appointment.

Thryv Holdings, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to be held virtually.

Norwegian Cruise Line Holdings Ltd. (NCLH) has announced its 2026 Annual General Meeting of Shareholders, scheduled for June 11, 2026, to vote on director elections, executive compensation, and amendments to its incentive plan.

Ridgepost Capital, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation votes, and auditor ratification.

OptimizeRx Corporation has issued its proxy statement detailing the agenda for its upcoming Annual Meeting of Shareholders on June 9, 2026, including proposals to amend its 2021 Equity Incentive Plan.

Q32 Bio Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for June 12, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.

Lexeo Therapeutics announces its 2026 Annual Meeting of Stockholders, scheduled for June 25, 2026, to elect directors and ratify auditors.

Foghorn Therapeutics Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 24, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Latch, Inc. (DOOR) has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, detailing proposals for director elections, auditor ratification, and executive compensation.

Unicycive Therapeutics announces its 2026 Annual Meeting of Stockholders, scheduled for June 19, 2026, to elect directors and ratify auditor appointment.

Rockwell Medical, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 12, 2026, which will include proposals for director elections, executive compensation approval, auditor ratification, and a reverse stock split.

Warner Bros. Discovery's 2026 Proxy Statement details director elections, executive compensation, and strategic decisions, including the proposed acquisition by Paramount Skydance.

Aprea Therapeutics, Inc. is holding its 2026 Annual Meeting of Stockholders on June 16, 2026, to vote on key proposals including a potential reverse stock split to maintain Nasdaq listing.

Build-A-Bear Workshop, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and executive compensation approval.

Trinity Capital Inc. has issued its proxy statement for the upcoming virtual annual meeting of stockholders on June 10, 2026, detailing proposals for director elections, auditor ratification, executive compensation votes, and stock plan amendments.